Clinical trial
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of…
NCT00033839 · Winston Laboratories, Industry · Completed
Key facts
| NCT number | NCT00033839 |
|---|---|
| Title | A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache |
| Official title | A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache |
| Lead sponsor | Winston Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Episodic Cluster Headache |
| Intervention type | Drug |
| Interventions | Civamide (Zucapsaicin) |
| Enrollment | 60 |
| Start date | Jan 1, 2002 |
| Primary completion | Jul 1, 2003 |
| Completion | Jul 1, 2003 |
| First posted | Apr 12, 2002 |
| Last update posted | Jun 10, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: